Clinical Trial Update: Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating top-down therapy for pediatric Crohn's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Pediatric Crohn's Disease | Phase 4 | Status: WITHDRAWN